Literature DB >> 28899793

Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies.

Xiaohai Zhang1, Nancy L Reinsmoen2.   

Abstract

The single antigen test is widely used in the field of transplantation to determine the specificity of HLA antibodies. It will be beneficial to standardize the procedure of the single antigen test among HLA laboratories. It is not uncommon that single antigen testing on native sera fails to detect antibodies with very high concentrations. It has been shown that cleavage products of activated complement components may mask strongly binding antibodies in single antigen testing. To overcome inhibition by the activated complement products, sera are pretreated with ethylenediaminetetraacetic acid (EDTA), dithiothreitol (DTT), or heat inactivation before single antigen testing. However, no studies have been published to systemically compare the impact of these treatments on single antigen testing. The aim of this study is to understand the different effects these treatments may have on single antigen test results. We found that mean fluorescence intensity (MFI) obtained from sera treated with EDTA and heat inactivation were nearly identical, while DTT treatment was less potent to remove the inhibition. In addition, sera dilution did not further increase MFI of antibodies after EDTA treatment. Our results provide guidance to choose a pretreatment reagent for single antigen testing, and to compare studies obtained from laboratories using different treatments.
Copyright © 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C1q; HLA antibody; Single antigen test; Transplant

Mesh:

Substances:

Year:  2017        PMID: 28899793     DOI: 10.1016/j.humimm.2017.09.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  1 in total

1.  IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from western Mexico.

Authors:  Luz E Chavarria-Buenrostro; Jorge Hernandez-Bello; Jose F Muñoz-Valle; Jose Macias-Barragan; Liliana B Hernandez-Carrillo; Jorge F Topete-Reyes; Renato Parra-Michel; Maria G Ramirez-Dueñas; Pedro E Sanchez-Hernandez; Ana L Pereira-Suarez; Eden Oceguera-Contreras; Margarita Montoya-Buelna
Journal:  J Clin Lab Anal       Date:  2018-10-21       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.